» Articles » PMID: 24501502

Anaesthetic Consideration During Laparoscopic Bilateral Simultaneous Nephrectomy

Overview
Specialty Gastroenterology
Date 2014 Feb 7
PMID 24501502
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Study Objective: To assess outcome from anaesthesia during laparoscopic bilateral simultaneous nephrectomy.

Design: Retrospective study.

Measurements: Preoperative Hb%, serum potassium, coagulation profile electrocardiography (ECG) changes, 2D Echography, x-ray chest, haemodynamic changes, end-tidal carbon dioxide (EtCO2), fluid management and postoperative analgesia.

Results: The mean age was 24.75 ± 14.35 years. The mean duration of surgery was 120 ± 80 minutes. The Hb%, serum creatinine and serum potassium were 9.4 ± 1.04%, 6.79 ± 4.91 meq/L and 3.61 ± 0.51 meq/L, respectively. Pulse rate mean blood pressure and EtCO2 were recorded after creation of pneumoperitoneum and at 15, 30, 45 and after exsufflation of pneumoperitoneum. After pneumoperitoneum, there was increase in pulse rate, systolic blood pressure, diastolic blood pressure and EtCO2. After 30 minutes and throughout the surgery, these variables remained stable. Four patients required nitroglycerine infusion for intraoperative hypertention. Only one patient required packed cell volume (PCV) transfusion and total intravenous fluid was 1 ± 0.5 L. At the time of exsufflation, there was decrease in pulse rate, systolic and diastolic blood pressure and EtCO2.

Conclusion: Because of advancement in anaesthetic agents and muscle relaxant, there is safe outcome from anaesthesia during laparoscopic bilateral simultaneous nephrectomy.

Citing Articles

Perianesthetic Management of Laparoscopic Kidney Surgery.

Nasrallah G, Souki F Curr Urol Rep. 2018; 19(1):1.

PMID: 29349580 DOI: 10.1007/s11934-018-0757-4.


Simultaneous bilateral laparoscopic nephrectomy in a child with peritoneal catheter dialysis using a 4-port trans-abdominal technique.

De Carli C, Guerra L Can Urol Assoc J. 2015; 9(1-2):59-61.

PMID: 25737759 PMC: 4336033. DOI: 10.5489/cuaj.2465.

References
1.
Thapa S, Brull S . Succinylcholine-induced hyperkalemia in patients with renal failure: an old question revisited. Anesth Analg. 2000; 91(1):237-41. DOI: 10.1097/00000539-200007000-00044. View

2.
Nishiyama T, Aibiki M, Hanaoka K . Inorganic fluoride kinetics and renal tubular function after sevoflurane anesthesia in chronic renal failure patients receiving hemodialysis. Anesth Analg. 1996; 83(3):574-7. DOI: 10.1097/00000539-199609000-00024. View

3.
Miller L, Sood M, Sood A, Reslerova M, Komenda P, Rigatto C . Cardiovascular disease in end-stage renal disease: the challenge of assessing and managing cardiac disease in dialysis patients. Int Urol Nephrol. 2010; 42(4):1007-14. DOI: 10.1007/s11255-010-9857-x. View

4.
Price L, Wort S, Finney S, Marino P, Brett S . Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review. Crit Care. 2010; 14(5):R169. PMC: 3219266. DOI: 10.1186/cc9264. View

5.
Dean M . Opioids in renal failure and dialysis patients. J Pain Symptom Manage. 2004; 28(5):497-504. DOI: 10.1016/j.jpainsymman.2004.02.021. View